Lambert‐eaton myasthenic syndrome: Immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity

Annals of Neurology

Volumn 25, Issue 3, 1989, Pages 265-271

  Lang, B ^a,c   Vincent, A ^a,c   Murray, N M F ^b   Newsom Davis J ^a,c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM;

ADULT; CLINICAL ARTICLE; EATON LAMBERT SYNDROME; FEMALE; HUMAN; LUNG CARCINOMA; MALE; PRIORITY JOURNAL;

ACTION POTENTIALS; ADULT; AGED; ANIMALS; CALCIUM CHANNELS; CARCINOMA, SMALL CELL; CELL LINE; FEMALE; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN HEAVY CHAINS; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; NEUROMUSCULAR DISEASES; RATS; TUMOR CELLS, CULTURED;

EID: 0024503862     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410250310     Document Type: Article

References (26)

1. Quantal components of end‐plate potentials in the myasthenic syndrome
2. On the release of transmitter at normal, myasthenia gravis, and myasthenic syndrome affected human end‐plates
3. The Lambert‐Eaton myasthenic syndrome: a review of 50 cases
4. Antigens of small‐cell lung cancer
5. Autoimmune aetiology for myasthenic (Eaton‐Lambert) syndrome
6. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse
7. Action of Lambert‐Eaton myasthenic syndrome IgG at mouse motor nerve terminals
8. Passively transferred Lambert‐Eaton syndrome in mice receiving purified IgG
9. The effects of myasthenic syndrome antibody on presynaptic calcium channels in the mouse
10. Paucity and disorganisation of presynaptic membrane active zones in the Lambert‐Eaton myasthenic syndrome
11. Are the presynaptic membrane particles the calcium channels?
12. Passive transfer of Lambert‐Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones
13. Lambert‐Eaton myasthenic syndrome: II. Immunoelectron microscopy localisation of IgG at the mouse motor end‐plate
14. Lambert‐Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones
15. 2+ flux in a human small cell carcinoma line
16. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
17. Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome
18. Purification of antiacetylcholine receptor antibody from patients with myasthenia gravis
19. Ectopic hormone production by bronchial carcinomas in culture
20. Biological characterisation and clinical applications of a monoclonal antibody recognising an antigen restricted to neuroectodermal tissues
21. Calcium uptake into rat pheochromocytoma cells
22. Sodium and calcium fluxes in a clonal nerve cell line
23. Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone release
24. IgG from patients with Lambert‐Eaton syndrome blocks voltage‐dependent calcium channels
25. The action of myasthenic syndrome antibody fragments on transmitter release in the mouse
26. Direct evidence that Lambert‐Eaton myasthenic syndrome IgG depletes the presynaptic membrane active zone particles by antigenic modulation